Assessing validity by comparing transition and static measures of dyspnea in patients with acute decompensated heart failure

Congestive Heart Failure

Volumn 16, Issue 5, 2010, Pages 202-207

  Smithline, Howard A ^a   Caglar, Selin ^a   Blank, Fidela S J ^a  

^a BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART FAILURE; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONVERGENT VALIDITY; CORRELATION ANALYSIS; DISEASE SEVERITY; DYSPNEA; FEMALE; HOSPITAL ADMISSION; HUMAN; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; PATIENT PARTICIPATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATIC MEASUREMENT; TRANSITION MEASUREMENT; VALIDITY; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; DIAGNOSTIC SELF EVALUATION; DISEASE PROGRESSION; DYSPNEA, PAROXYSMAL; EMERGENCY MEDICAL SERVICES; FEMALE; HEART FAILURE; HUMANS; MALE; OBSERVATION; PAIN MEASUREMENT; PHYSICIANS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF REPORT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; WEIGHTS AND MEASURES;

EID: 77957065392     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2010.00152.x     Document Type: Article

References (14)

1. Food and Drug Administrator. http://www.fda.gov/ohrms/dockets/ac/98/transcpt/3462t1.pdf, Center for Drug Evaluation and Research, Transcript of the 86th Meeting of the Cardiovascular and Renal Drugs Advisory Committee; Thursday, October 22, 1998. Available at: Accessed July 1, 2008
2. Food and Drug Administrator. http://www.fda.gov/ohrms/dockets/ac/99/transcpt/3490t2.pdf, Center for Drug Evaluation and Research, Transcript of the 87th Meeting of the Cardiovascular and Renal Drugs Advisory Committee; Thursday, January 29, 1999. Available at: Accessed July 1, 2008
3. Teerlink J. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure. Am Heart J 2003, 145:S26-S33.
4. Pang PS, Cleland JG, Teerlink JR. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 2008, 29(6):816-824.
5. Smithline H, Caglar S, Blank F. Physician vs patient assessment of dyspnea during acute decompensated heart failure. Congest Heart Fail 2010
6. Adams L, Chronos N, Lane R. The measurement of breathlessness induced in normal subjects: validity of two scaling techniques. Clin Sci (Lond) 1985, 69(1):7-16.
7. Gift AG, Narsavage G. Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care 1998, 7(3):200-204.
8. Mahler DA, Mejia-Alfaro R, Ward J. Continuous measurement of breathlessness during exercise: validity, reliability, and responsiveness. J Appl Physiol 2001, 90(6):2188-2196.
9. Fischer D, Stewart AL, Bloch DA. Capturing the patient's view of change as a clinical outcome measure. JAMA 1999, 282(12):1157-1162.
10. Guyatt GH, Norman GR, Juniper EF. A critical look at transition ratings. J Clin Epidemiol 2002, 55(9):900-908.
11. Stata Statistical Software [computer program] 2007, Version 10, College Station, TX, Stata Corporation
12. Ander DS, Aisiku IP, Ratcliff JJ. Measuring the dyspnea of decompensated heart failure with a visual analog scale: how much improvement is meaningful? Congest Heart Fail 2004, 10(4):188-191.
13. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med 1999, 159(1):321-340.
14. Ross M. Relation of implicit theories to the construction of personal histories. Psychol Rev 1989, 96(2):341-357.